# ReoPro and Retavase to Treat Acute Stroke

> **NCT00046293** · PHASE2 · COMPLETED · sponsor: **National Institute of Neurological Disorders and Stroke (NINDS)** · enrollment: 72 (estimated)

## Conditions studied

- Cerebrovascular Accident

## Interventions

- **DRUG:** Reopro
- **DRUG:** Retrovase

## Key facts

- **NCT ID:** NCT00046293
- **Lead sponsor:** National Institute of Neurological Disorders and Stroke (NINDS)
- **Sponsor class:** NIH
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2002-09-24
- **Primary completion:** 2007-07-20
- **Final completion:** 2007-07-20
- **Target enrollment:** 72 (ESTIMATED)
- **Last updated:** 2017-07-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00046293

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00046293, "ReoPro and Retavase to Treat Acute Stroke". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT00046293. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*